Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8555373 | 8152079 | F | 8555373-5 | 20120223 | 20120731 | PER | US-ASTRAZENECA-2011SE28129 | AZPRODUW00 | 49 | YR | M | Y | 90.7 | KG | 20120801 | CN | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8555373 | 1020409427 | PS | SEROQUEL XR | 1 | ORAL | 022047 | |||||
| 8555373 | 1020409430 | SS | SEROQUEL XR | 1 | ORAL | 022047 | |||||
| 8555373 | 1020409429 | SS | SEROQUEL XR | 1 | ORAL | 022047 | |||||
| 8555373 | 1020409432 | C | POLNAPIN | 2 | |||||||
| 8555373 | 1020409431 | C | LEXAPRO | 1 | |||||||
| 8555373 | 1020409428 | SS | SEROQUEL XR | 1 | ORAL | 022047 | |||||
| 8555373 | 1020409433 | C | POLNAPIN | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8555373 | 1020409427 | ATTENTION DEFICIT/HYPERACTIVITY DISORDER |
| 8555373 | 1020409432 | DEPRESSION |
| 8555373 | 1020409431 | DEPRESSION |
| 8555373 | 1020409428 | BIPOLAR DISORDER |
| 8555373 | 1020409433 | SLEEP DISORDER |
Outcome of event
| no results found |
Reactions reported
| Event ID | PT |
|---|---|
| 8555373 | AGORAPHOBIA |
| 8555373 | OFF LABEL USE |
| 8555373 | WEIGHT FLUCTUATION |
| 8555373 | BIPOLAR DISORDER |
| 8555373 | DRUG DOSE OMISSION |
| 8555373 | DRUG DISPENSING ERROR |
| 8555373 | SLEEP DISORDER |
| 8555373 | INTERVERTEBRAL DISC DEGENERATION |
| 8555373 | BODY HEIGHT DECREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |